![Ernesto Aycardi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ernesto Aycardi
Keine laufenden Positionen mehr
Profil
Ernesto Aycardi worked as Senior Director-Worldwide Clinical Research at Merck & Co., Inc. from 1998 to 2009.
From 2009 to 2013, worked as Director-Medical Research at Biogen Canada, Inc. Between 2013 and 2014, worked as Senior Director at EMD Serono, Inc. From 2014 to 2018, worked as Vice President & Head-Clinical Trial Operations at Teva Pharmaceutical Industries Ltd. From 2018 to 2021, worked as Chief Medical Officer at Xenon Pharmaceuticals, Inc. Completed a doctorate degree at Universidad Nacional de Colombia.
Ehemalige bekannte Positionen von Ernesto Aycardi
| Unternehmen | Position | Ende |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.04.2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01.01.2014 |
Biogen Canada, Inc.
 Biogen Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Biogen, Inc., Biogen Canada, Inc. is a biotechnology company that develops therapies for complex and devastating diseases, focusing on neurology, neuropsychiatry, specialized immunology, and rare diseases. The company is based in Mississauga, Canada. The Canadian company has created medicines for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer ’ s disease, and supports clinical trials, early access programs, and safe medicine manufacturing. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
| MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Ausbildung von Ernesto Aycardi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Universidad Nacional de Colombia
 Universidad Nacional de Colombia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Canada, Inc.
Biogen Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Biogen, Inc., Biogen Canada, Inc. is a biotechnology company that develops therapies for complex and devastating diseases, focusing on neurology, neuropsychiatry, specialized immunology, and rare diseases. The company is based in Mississauga, Canada. The Canadian company has created medicines for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer ’ s disease, and supports clinical trials, early access programs, and safe medicine manufacturing. | Commercial Services |
Wählen Sie MarketScreener 
